Investment Summary

META Exits HEXO

On January 24, 2019, invested in medical products company HEXO from META

Investment Highlights
  • This is transaction in the Medical Products sector.
  • This is transaction in Canada.
  • This is transaction in Quebec.
Investment Fate
  • HEXO was sold to a strategic buyer in 2023.

Investment Summary

Date 2019-01-24
Target HEXO
Sector Medical Products
Sellers(s) META
Deal Type IPO

Target

HEXO

Gatineau, Quebec, Canada
HEXO is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. As one of the largest licensed cannabis companies in Canada, HEXO Corp operates with 1.8 million sq. ft of facilities in Ontario and Quebec and a foothold in Greece to establish a Eurozone processing, production and distribution centre. HEXO was founded in 2013 and is based in Gatineau, Canada.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Seller(S) 1

SELLER

META

Etobicoke, Ontario, Canada

Category Company
Founded 2014
Sector Consumer Products
Employees301
Revenue 54M CAD (2019)
DESCRIPTION

META is a manufacturer and marketer of medical marijuana products in Canada and internationally. META was founded in 2014 and is based in Brampton, Canada.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: IPO M&A Deals 1 of 1
State: Quebec M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2019 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-20 HEXO

Gatineau, Quebec, Canada

HEXO is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. As one of the largest licensed cannabis companies in Canada, HEXO Corp operates with 1.8 million sq. ft of facilities in Ontario and Quebec and a foothold in Greece to establish a Eurozone processing, production and distribution centre. HEXO was founded in 2013 and is based in Gatineau, Canada.

Buy $21M